Page last updated: 2024-11-01

ondansetron and Cephalgia Syndromes

ondansetron has been researched along with Cephalgia Syndromes in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
"The merged early incidence of postoperative nausea and vomiting (PONV) in ondansetron group (42."8.89Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. ( Cheng, NS; Lin, YX; Wu, SJ; Xiong, XZ, 2013)
"The merged early incidence of postoperative nausea and vomiting (PONV) in ondansetron group (42."4.89Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. ( Cheng, NS; Lin, YX; Wu, SJ; Xiong, XZ, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, SJ1
Xiong, XZ1
Lin, YX1
Cheng, NS1

Reviews

1 review available for ondansetron and Cephalgia Syndromes

ArticleYear
Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis.
    Surgical laparoscopy, endoscopy & percutaneous techniques, 2013, Volume: 23, Issue:1

    Topics: Antiemetics; Cholecystectomy, Laparoscopic; Granisetron; Headache Disorders; Humans; Ondansetron; Po

2013